Search Within

Han Liu

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
Groups
  1. Department of Pathology and Laboratory Medicine (13)
  2. GSK Faculty (13)
  3. Human Oncology and Pathogenesis Program (13)
  4. Sloan Kettering Institute Postdocs (12)
  5. Department of Medicine (8)
  6. Genitourinary Oncology Service (8)

More Groups

People
  1. James Hsieh (12)
  2. Shugaku Takeda (12)
  3. Emily Cheng (10)
  4. Abraham Hakimi (8)
  5. Martin Voss (8)
  6. Robert Motzer (8)

More People

Years
  1. 2017 (1)
  2. 2014 (2)
  3. 2013 (6)
  4. 2012 (4)
Publications
  1. BJU International (2)
  2. Cancer Research (2)
  3. Clinical Cancer Research (2)
  4. Journal of Clinical Oncology (2)
  5. Cancer Cell (1)
  6. Cell Reports (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (2)
  3. Cell Press (2)
  4. Wiley Blackwell (2)
  5. American Association for the Advancement of Science (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ΔNp63 inhibits oxidative stress-induced cell death, including ferroptosis, and cooperates with the BCL-2 family to promote clonogenic survival
    Journal Article

    Wang, G. X.; Tu, H. C.; Dong, Y.; Skanderup, A. J.; Wang, Y.; Takeda, S.; Ganesan, Y. T.; Han, S.; Liu, H.; Hsieh, J. J.; more...
    Cell Reports (2017)

    Fulltext@MSK | Save
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Proteasome inhibitors evoke latent tumor suppression programs in Pro-B MLL Leukemias through MLL-AF4
    Journal Article

    Liu, H.; Westergard, T. D.; Cashen, A.; Piwnica-Worms, D. R.; Kunkle, L.; Vij, R.; Pham, C. G.; DiPersio, J.; Cheng, E. H.; Hsieh, J. J.
    Cancer Cell (2014)

    Fulltext@MSK | Save
  • Effective monotherapy despite intratumor heterogeneity: Clonal convergence within the PI3K pathway and sensitivity to mTOR inhibitors in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Chen, Y.; Pham, C. G.; Brannon, A. R.; Scott, S. N.; Takeda, S.; Liu, H.; Motzer, R. J.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma
    Journal Article

    Takeda, S.; Liu, H.; Sasagawa, S.; Dong, Y.; Trainor, P. A.; Cheng, E. H.; Hsieh, J. J.
    Journal of Clinical Investigation (2013)

    Fulltext@MSK | Save
  • Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA research network
    Journal Article

    Hakimi, A. A.; Ostrovnaya, I.; Reva, B.; Schultz, N.; Chen, Y. B.; Gonen, M.; Liu, H.; Takeda, S.; Voss, M. H.; Tickoo, S. K.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; Reuter, V. E.; more...
    European Urology (2013)

    Fulltext@MSK | Save
  • PUMA and BIM are required for oncogene inactivation-induced apoptosis
    Journal Article

    Bean, G. R.; Ganesan, Y. T.; Dong, Y.; Takeda, S.; Liu, H.; Chan, P. M.; Huang, Y.; Chodosh, L. A.; Zambetti, G. P.; Hsieh, J. J. D.; more...
    Science Signaling (2013)

    Fulltext@MSK | Save
  • Genetic determinants of long-term response to rapalog therapy in advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Scott, S. N.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save